Morbidity associated with oral corticosteroids in patients with severe asthma

被引：12
|
作者：
Choo, Xue Ning [1 ]
Pavord, Ian D. [1 ]
机构：
[1] Univ Oxford, Nuffield Dept Med, Resp Med Unit, NDM Res Bldg,Old Rd Campus, Oxford OX3 7FZ, England
来源：
THORAX | 2016年 / 71卷 / 04期
关键词：
RANDOMIZED CONTROLLED-TRIAL; SEVERE EOSINOPHILIC ASTHMA; EXHALED NITRIC-OXIDE; ADVERSE EVENTS; ECONOMIC-IMPLICATIONS; RHEUMATOID-ARTHRITIS; CUMULATIVE BURDEN; DOUBLE-BLIND; MEPOLIZUMAB; PLACEBO;
D O I：
10.1136/thoraxjnl-2015-208242
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：302 / 304
页数：3
相关论文
共 50 条
  • [21] Quantification of Glucocorticoid-Associated Morbidity in Severe Asthma Using the Glucocorticoid Toxicity Index
    McDowell, P. Jane
    Stone, John H.
    Zhang, Yuqing
    Honeyford, Kirsty
    Dunn, Louise
    Logan, R. Jayne
    Butler, Claire A.
    McGarvey, Lorcan P. A.
    Heaney, Liam G.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (01) : 365 - 372.e5
  • [22] Pragmatic Clinical Perspective on Biologics for Severe Refractory Type 2 Asthma
    Chan, Rory
    Kuo, Chris RuiWen
    Lipworth, Brian
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (10) : 3363 - 3370
  • [23] Novel monoclonal treatments in severe asthma
    Meteran, Howraman
    Meteran, Hanieh
    Porsbjerg, Celeste
    Backer, Vibeke
    JOURNAL OF ASTHMA, 2017, 54 (10) : 991 - 1011
  • [24] Benralizumab Reduces Respiratory Exacerbations and Oral Glucocorticosteroid Dose in Patients with Severe Asthma and Eosinophilic Granulomatosis with
    Muemmler, Carlo
    Mertsch, Pontus
    Barnikel, Michaela
    Haubner, Frank
    Schoenermarck, Ulf
    Grabmaier, Ulrich
    Schulze-Koops, Hendrik
    Behr, Juergen
    Kneidinger, Nikolaus
    Milger, Katrin
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 557 - 572
  • [25] Future Risks in Patients With Severe Asthma
    Song, Woo-Jung
    Lee, Ji-Hyang
    Kang, Yewon
    Joung, Woo Joung
    Chung, Kian Fan
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2019, 11 (06) : 763 - 778
  • [26] Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma
    d'Ancona, Grainne
    Kavanagh, Joanne
    Roxas, Cris
    Green, Linda
    Fernandes, Mariana
    Thomson, Louise
    Dhariwal, Jaideep
    Nanzer, Alexandra M.
    Jackson, David J.
    Kent, Brian D.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (05)
  • [27] Anti-Interleukin-5 Therapy Is Associated with Attenuated Lung Function Decline in Severe Eosinophilic Asthma Patients From the Belgian Severe Asthma Registry
    Graff, Sophie
    Brusselle, Guy
    Hanon, Shane
    Sohy, Carine
    Dupont, Lieven
    Peche, Rudy
    Michils, Alain
    Pilette, Charles
    Joos, Guy
    Lahousse, Lies
    Lapperre, Therese
    Louis, Renaud
    Schleich, Florence
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (02) : 467 - 477
  • [28] Oral versus intravenous corticosteroids in adults hospitalised with acute asthma
    Cunnington, D
    Smith, N
    Steed, K
    Rosengarten, P
    Kelly, AM
    Teichtahl, H
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2005, 18 (03) : 207 - 212
  • [29] Modifiable factors associated with severe asthma exacerbations in urban patients
    Talreja, Neetu
    Soubani, Ayman O.
    Sherwin, Robert L.
    Baptist, Alan P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (02) : 128 - 132
  • [30] Biomarkers in Severe Asthma
    Wan, Xiao Chloe
    Woodruff, Prescott G.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2016, 36 (03) : 547 - +
12345